Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajesh Sankaranarayanan

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Advances in Experimental Medicine and Biology|April 30, 2009
Synthesis of bivalent MSH ligands and evaluation of their binding to hMC4R using MSH lanthaligandSteve M Fernandes, Rajesh Sankaranarayanan, Liping Xu, et al.
International Journal of Peptide Research and Therapeutics|August 29, 2009
Solid-Phase Synthesis of Heterobivalent Ligands Targeted to Melanocortin and Cholecystokinin ReceptorsJatinder S Josan, Josef Vagner, Heather L Handl, et al.
Bioconjugate Chemistry|June 27, 2007
Synthesis and evaluation of bivalent NDP-alpha-MSH(7) peptide ligands for binding to the human melanocortin receptor 4 (hMC4R)Heather L Handl, Rajesh Sankaranarayanan, Jatinder S Josan, et al.
Bioorganic & Medicinal Chemistry Letters|April 24, 2007
Squalene-derived flexible linkers for bioactive peptidesBhumasamudram Jagadish, Rajesh Sankaranarayanan, Liping Xu, et al.
Advances in Experimental Medicine and Biology|April 30, 2009
Heterobivalent ligands crosslink multiple cell-surface receptors--a step towards personal medicineJatinder S Josan, Rajesh Sankaranarayanan, Heather L Handl, et al.
Bioconjugate Chemistry|June 7, 2011
Cell-specific targeting by heterobivalent ligandsJatinder S Josan, Heather L Handl, Rajesh Sankaranarayanan, et al.
The Journal of Organic Chemistry|February 7, 2007
Design, synthesis, and validation of a branched flexible linker for bioactive peptidesMartina E Bowen, Yasunari Monguchi, Rajesh Sankaranarayanan, et al.
Journal of Medicinal Chemistry|June 1, 2018
Identification of Highly Potent Human Immunodeficiency Virus Type-1 Protease Inhibitors against Lopinavir and Darunavir Resistant Viruses from Allophenylnorstatine-Based Peptidomimetics with P2 TetrahydrofuranylglycineKoushi Hidaka, Tooru Kimura, Rajesh Sankaranarayanan, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Advances in Experimental Medicine and Biology|April 30, 2009
Synthesis of bivalent MSH ligands and evaluation of their binding to hMC4R using MSH lanthaligandSteve M Fernandes, Rajesh Sankaranarayanan, Liping Xu, et al.
International Journal of Peptide Research and Therapeutics|August 29, 2009
Solid-Phase Synthesis of Heterobivalent Ligands Targeted to Melanocortin and Cholecystokinin ReceptorsJatinder S Josan, Josef Vagner, Heather L Handl, et al.
Bioconjugate Chemistry|June 27, 2007
Synthesis and evaluation of bivalent NDP-alpha-MSH(7) peptide ligands for binding to the human melanocortin receptor 4 (hMC4R)Heather L Handl, Rajesh Sankaranarayanan, Jatinder S Josan, et al.
Bioorganic & Medicinal Chemistry Letters|April 24, 2007
Squalene-derived flexible linkers for bioactive peptidesBhumasamudram Jagadish, Rajesh Sankaranarayanan, Liping Xu, et al.
Advances in Experimental Medicine and Biology|April 30, 2009
Heterobivalent ligands crosslink multiple cell-surface receptors--a step towards personal medicineJatinder S Josan, Rajesh Sankaranarayanan, Heather L Handl, et al.
Bioconjugate Chemistry|June 7, 2011
Cell-specific targeting by heterobivalent ligandsJatinder S Josan, Heather L Handl, Rajesh Sankaranarayanan, et al.
The Journal of Organic Chemistry|February 7, 2007
Design, synthesis, and validation of a branched flexible linker for bioactive peptidesMartina E Bowen, Yasunari Monguchi, Rajesh Sankaranarayanan, et al.
Journal of Medicinal Chemistry|June 1, 2018
Identification of Highly Potent Human Immunodeficiency Virus Type-1 Protease Inhibitors against Lopinavir and Darunavir Resistant Viruses from Allophenylnorstatine-Based Peptidomimetics with P2 TetrahydrofuranylglycineKoushi Hidaka, Tooru Kimura, Rajesh Sankaranarayanan, et al.
Pageof 1